Cargando…
Recently published papers: Therapies failed, disputed, and beneficent
A recent meta-analysis puts another nail in the coffin of a therapy that held great promise for management of acute respiratory distress syndrome. Two papers further highlight the growing controversy surrounding the safety profile of drotrecogin alfa (activated) and increase the clamour for a new in...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206422/ https://www.ncbi.nlm.nih.gov/pubmed/17578561 http://dx.doi.org/10.1186/cc5931 |
| _version_ | 1782148468162166784 |
|---|---|
| author | Williams, Gareth |
| author_facet | Williams, Gareth |
| author_sort | Williams, Gareth |
| collection | PubMed |
| description | A recent meta-analysis puts another nail in the coffin of a therapy that held great promise for management of acute respiratory distress syndrome. Two papers further highlight the growing controversy surrounding the safety profile of drotrecogin alfa (activated) and increase the clamour for a new independent trial. Also covered are steroids and their role in preventing postoperative atrial fibrillation, and success in instituting hypothermia after cardiac arrest. Finally, which form of renal replacement therapy should we be using in the intensive care unit? |
| format | Text |
| id | pubmed-2206422 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-22064222008-01-19 Recently published papers: Therapies failed, disputed, and beneficent Williams, Gareth Crit Care Commentary A recent meta-analysis puts another nail in the coffin of a therapy that held great promise for management of acute respiratory distress syndrome. Two papers further highlight the growing controversy surrounding the safety profile of drotrecogin alfa (activated) and increase the clamour for a new independent trial. Also covered are steroids and their role in preventing postoperative atrial fibrillation, and success in instituting hypothermia after cardiac arrest. Finally, which form of renal replacement therapy should we be using in the intensive care unit? BioMed Central 2007 2007-06-18 /pmc/articles/PMC2206422/ /pubmed/17578561 http://dx.doi.org/10.1186/cc5931 Text en Copyright © 2007 BioMed Central Ltd |
| spellingShingle | Commentary Williams, Gareth Recently published papers: Therapies failed, disputed, and beneficent |
| title | Recently published papers: Therapies failed, disputed, and beneficent |
| title_full | Recently published papers: Therapies failed, disputed, and beneficent |
| title_fullStr | Recently published papers: Therapies failed, disputed, and beneficent |
| title_full_unstemmed | Recently published papers: Therapies failed, disputed, and beneficent |
| title_short | Recently published papers: Therapies failed, disputed, and beneficent |
| title_sort | recently published papers: therapies failed, disputed, and beneficent |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206422/ https://www.ncbi.nlm.nih.gov/pubmed/17578561 http://dx.doi.org/10.1186/cc5931 |
| work_keys_str_mv | AT williamsgareth recentlypublishedpaperstherapiesfaileddisputedandbeneficent |